Vitruvia Medical AG (MUN:991)

Vitruvia Medical AG Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2020
Period Ending	Dec 31, 2020
Net Income	-1.54
Depreciation & Amortization	0.35
Change in Accounts Receivable	-0.81
Change in Accounts Payable	0.78
Change in Other Net Operating Assets	1.01
Operating Cash Flow	-0.21
Capital Expenditures	-2.91
Other Investing Activities	0.71
Investing Cash Flow	-2.2
Issuance of Common Stock	2.83
Financing Cash Flow	2.83
Foreign Exchange Rate Adjustments	0.02
Net Cash Flow	0.44
Free Cash Flow	-3.12
Free Cash Flow Margin	-54.11%
Free Cash Flow Per Share	-2.12
Change in Working Capital	0.98

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 3, 2026

Data Sources Report a data error